Lampley branched into drug development at the industrial level where he served as a clinical research associate for large CROs such as Icon and PPD before starting his own clinical development consulting firm, Lampgen Clinical Research. From there, he moved on to clinical research at Georgetown University where he developed a genetic test for determining the one’s risk of developing diabetes and weight gain along with the protocol for the subsequent Phase 1 clinical trial. Lampley has over 12 years of research experience with his career beginning at Morehouse College where he focused on isolating various proteins implicated in a rare form of diabetes. in Biotechnology with a concentration in Drug Design and Discovery. He is also graduate of Georgetown University School of Medicine where he received an M.S. in Biology and minors in Neuroscience and Psychology. Lampley attended Morehouse College where he obtained a B.S. Tommy Lampley, M.S is a co-founder and President of Synergy Healthcare. He has more than 17 years of clinical research experience. Weston began his research career at the Duke Clinical Research Institute where he focused on cardiovascular research. And he also received an MBA from the Northwestern Kellogg School of Management. He is a graduate of the University of Pittsburgh School of Medicine where he received an M.D.

Weston, attended the Pennsylvania State University where he obtained a B.S. Weston is a trained internist and cardiologist, and is a co-founder and CEO of Synergy Healthcare. We strive to provide quality services to our sponsors and participants.

We are comprised of a team of clinical research and healthcare professionals in a network of specially-designed sites. We do this by sharing our clinical research expertise in partnership with bio-pharmaceutical, healthcare systems and clinical research organizations. The commitment to the advancement of medicine and improvements of health outcomes.

Synergy healthcare